Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGP 51901

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Summary and conclusionA summary of the properties of CGP 51901 is shown in Table 3. On the basis of its binding to IgE and IgE… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2000
2000
  • M. Kupczyk, P. Kuna
  • Polski merkuriusz lekarski : organ Polskiego…
  • 2000
  • Corpus ID: 32019584
IgE antibodies play a key role in the development of allergic reactions. Non-specific immunotherapy which enables to control the… Expand
1999
1999
1. Racine-Poon A, 2. Botta L, 3. Chang TW, 4. et al. (1997) Clin Pharmacol Ther. 62:675–690. [OpenUrl][1][CrossRef][2… Expand
1997
1997
The efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, a recombinant monoclonal mouse—human chimeric anti‐human… Expand
Highly Cited
1997
Highly Cited
1997
CGP 51901 is a non-anaphylactogenic mouse/human chimeric anti-human IgE antibody that binds to free IgE and surface IgE of IgE… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • figure 3